Know Labs, which is developing a non-invasive glucose monitor using biosensor technology, filed on Friday with the SEC to raise up to $6 million in an initial public offering. The company is currently listed on the OTC (KNWN).
The Seattle, WA-based company plans to raise $6 million by offering 3 million shares at $2. At the proposed price, Know Labs would command a fully diluted market value of $123 million.
Know Labs is focused on the development and commercialization of proprietary biosensor technologies which, when paired with its AI deep learning platform, are capable of identifying and measuring materials and analytes (the Bio-RFID technology platform). The early-stage company is initially using its Bio-RFID technology to develop a non-invasive glucose monitor.
Know Labs was founded in 1998 and booked $4 million in revenue for the 12 months ended March 31, 2022. It plans to list on the NYSE American under the symbol KNW. Boustead Securities is the sole bookrunner on the deal.
